Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$6.71 - $10.16 $127 - $193
-19 Reduced 0.12%
16,290 $151,000
Q3 2023

Nov 08, 2023

BUY
$9.35 - $14.32 $5,825 - $8,921
623 Added 3.97%
16,309 $161,000
Q1 2023

May 12, 2023

BUY
$10.23 - $14.76 $17,022 - $24,560
1,664 Added 11.87%
15,686 $183,000
Q4 2022

Jan 19, 2023

BUY
$6.86 - $11.32 $2,977 - $4,912
434 Added 3.19%
14,022 $149,000
Q3 2022

Nov 01, 2022

BUY
$9.3 - $18.27 $2,371 - $4,658
255 Added 1.91%
13,588 $132,000
Q2 2022

Jul 29, 2022

SELL
$11.79 - $27.63 $20,043 - $46,971
-1,700 Reduced 11.31%
13,333 $193,000
Q1 2022

May 11, 2022

BUY
$20.67 - $40.33 $182,784 - $356,638
8,843 Added 142.86%
15,033 $393,000
Q4 2021

Jan 10, 2022

BUY
$36.68 - $54.02 $227,049 - $334,383
6,190 New
6,190 $245,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.